Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Cisplatin vs FEC-T in Triple Negative Breast Cancer
NCT01216111Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jan 2011
- Primary completion
- Apr 2016
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132) in triple negative breast cancer (TNBC), sponsored by Fudan University. Started Jan 2011; status: completed.
02
Drugs
Paclitaxel Micelles for InjectionCisplatin micelle injection (HA132)
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01216111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216111.